[{"Assets_0_Q3_USD":277693000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":161754000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":72000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":113363000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":113444000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":100936000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":100806000.0,"StockholdersEquity_0_Q3_USD":-111357000.0,"EarningsPerShareBasic_1_Q3_USD":0.47,"EarningsPerShareBasic_3_Q3_USD":1.3,"EarningsPerShareDiluted_1_Q3_USD":0.43,"EarningsPerShareDiluted_3_Q3_USD":1.19,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":61680000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":181146000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181031"}]